{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:45:19Z","timestamp":1792813519527,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001352","name":"National University of Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001352","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004396","name":"Thailand Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004396","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013238","name":"Faculty of Medicine Siriraj Hospital, Mahidol University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013238","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.ijantimicag.2019.04.004","type":"journal-article","created":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T18:59:27Z","timestamp":1555009167000},"page":"109-116","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Comparisons of whole-genome sequencing and phenotypic drug susceptibility testing for Mycobacterium tuberculosis causing MDR-TB and XDR-TB in Thailand"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5022-4182","authenticated-orcid":false,"given":"Kiatichai","family":"Faksri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orawee","family":"Kaewprasert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rick Twee-Hee","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prapat","family":"Suriyaphol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therdsak","family":"Prammananan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yik-Ying","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prapaporn","family":"Srilohasin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angkana","family":"Chaiprasert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0001","series-title":"Global tuberculosis report 2016","year":"2016"},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169798","article-title":"Diagnostic accuracy of GeneXpert MTB\/RIF assay in comparison to conventional drug susceptibility testing method for the diagnosis of multidrug-resistant tuberculosis","volume":"12","author":"Pandey","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0003","doi-asserted-by":"crossref","first-page":"1601075","DOI":"10.1183\/13993003.01075-2016","article-title":"Accuracy of line probe assays for the diagnosis of pulmonary and multidrug-resistant tuberculosis: a systematic review and meta-analysis","volume":"49","author":"Nathavitharana","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0004","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S2213-2600(15)00466-X","article-title":"Rapid, comprehensive, and affordable mycobacterial diagnosis with whole-genome sequencing: a prospective study","volume":"4","author":"Pankhurst","year":"2016","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0005","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.01480-17","article-title":"Evaluation of whole-genome sequencing for mycobacterial species identification and drug susceptibility testing in a clinical setting: a large-scale prospective assessment of performance against line probe assays and phenotyping","volume":"56","author":"Quan","year":"2018","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0006","unstructured":"CRyPTIC Consortium and 100, 000 Genomes Project. Prediction of susceptibility to first-line tuberculosis drugs by DNA sequencing. N Engl J Med 2018:1\u201314."},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0007","article-title":"Whole genome sequencing based characterization of extensively drug-resistant Mycobacterium tuberculosis isolates from Pakistan","volume":"10","author":"Ali","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0008","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S1473-3099(15)00062-6","article-title":"Whole-genome sequencing for prediction of Mycobacterium tuberculosis drug susceptibility and resistance: a retrospective cohort study","volume":"15","author":"Walker","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0009","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13073-015-0164-0","article-title":"Rapid determination of anti-tuberculosis drug resistance from whole-genome sequences","volume":"7","author":"Coll","year":"2015","journal-title":"Genome Med"},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0010","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1128\/JCM.00025-15","article-title":"PhyResSE: a web tool delineating Mycobacterium tuberculosis antibiotic resistance and lineage from whole-genome sequencing data","volume":"53","author":"Feuerriegel","year":"2015","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0011","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.cmi.2018.03.041","article-title":"Evaluation of whole genome sequencing and software tools for drug susceptibility testing of Mycobacterium tuberculosis","volume":"25","author":"van Beek","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0012","doi-asserted-by":"crossref","first-page":"46327","DOI":"10.1038\/srep46327","article-title":"Mycobacterium tuberculosis resistance prediction and lineage classification from genome sequencing: comparison of automated analysis tools","volume":"7","author":"Schleusener","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0013","first-page":"72","article-title":"Guidelines for surveillance of drug resistance in tuberculosis. WHO Geneva\/IUATLD Paris. International Union Against Tuberculosis and Lung Disease","volume":"2","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0014","series-title":"Genetic manipulation of Mycobacterium tuberculosis. Current protocols in microbiology","author":"Larsen","year":"2007"},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0015","article-title":"FastQC A quality control tool for high throughput sequence data","author":"Andrews","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0016","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0017","first-page":"3997","article-title":"Aligning sequence reads, clone sequences and assembly contigs with BWA-MEM","volume":"1303","author":"Li","year":"2013","journal-title":"arXiv preprint arXiv"},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0018","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The Sequence Alignment\/Map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0019","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res"},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0020","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.meegid.2016.09.013","article-title":"Bioinformatics tools and databases for whole genome sequence analysis of Mycobacterium tuberculosis","volume":"45","author":"Faksri","year":"2016","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0021","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13073-016-0385-x","article-title":"The variability and reproducibility of whole genome sequencing technology for detecting resistance to anti-tuberculous drugs","volume":"8","author":"Phelan","year":"2016","journal-title":"Genome Med"},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0022","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cmi.2016.09.008","article-title":"Whole genome sequencing of Mycobacterium tuberculosis for detection of drug resistance: a systematic review","volume":"23","author":"Papaventsis","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0023","doi-asserted-by":"crossref","first-page":"24","DOI":"10.5588\/ijtld.15.0221","article-title":"Clinical implications of molecular drug resistance testing for Mycobacterium tuberculosis: a TBNET\/RESIST-TB consensus statement","volume":"20","author":"Dominguez","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0024","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.1128\/JCM.40.11.3976-3979.2002","article-title":"Multicenter evaluation of ethambutol susceptibility testing of Mycobacterium tuberculosis by agar proportion and radiometric methods","volume":"40","author":"Madison","year":"2002","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0025","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108911","article-title":"Re-evaluation of the critical concentration for ethambutol antimicrobial sensitivity testing on the MGIT 960","volume":"9","author":"Christianson","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0026","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/167954","article-title":"Mutations in the embB gene and their association with ethambutol resistance in multidrug-resistant Mycobacterium tuberculosis clinical isolates from Poland","volume":"2013","author":"Bakula","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0027","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1159\/000343474","article-title":"embB306 mutations as molecular indicators to predict ethambutol susceptibility in Mycobacterium tuberculosis","volume":"58","author":"Sirgel","year":"2012","journal-title":"Chemotherapy"},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0028","doi-asserted-by":"crossref","first-page":"e01279-17","DOI":"10.1128\/AAC.01279-17","article-title":"Mutations within embCAB are associated with variable level of ethambutol resistance in Mycobacterium tuberculosis isolates from China","volume":"62","author":"Sun","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0029","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1128\/JCM.02724-12","article-title":"Diagnostic accuracy and reproducibility of WHO-endorsed phenotypic drug susceptibility testing methods for first-line and second-line antituberculosis drugs","volume":"51","author":"Horne","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0030","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1128\/JCM.02083-07","article-title":"Inter- and intra-assay reproducibility of microplate Alamar blue assay results for isoniazid, rifampicin, ethambutol, streptomycin, ciprofloxacin, and capreomycin drug susceptibility testing of Mycobacterium tuberculosis","volume":"46","author":"Leonard","year":"2008","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0031","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1056\/NEJMc1215305","article-title":"Whole-genome sequencing for rapid susceptibility testing of M. tuberculosis","volume":"369","author":"Koser","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0032","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.diagmicrobio.2013.06.031","article-title":"Mycobacterium tuberculosis rrs A1401G mutation correlates with high-level resistance to kanamycin, amikacin, and capreomycin in clinical isolates from mainland China","volume":"77","author":"Du","year":"2013","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0033","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.diagmicrobio.2016.05.010","article-title":"Molecular analysis of genetic mutations among cross-resistant second-line injectable drugs reveals a new resistant mutation in Mycobacterium tuberculosis","volume":"85","author":"Malinga","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0034","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1128\/AAC.00851-09","article-title":"High level of cross-resistance between kanamycin, amikacin, and capreomycin among Mycobacterium tuberculosis isolates from Georgia and a close relation with mutations in the rrs gene","volume":"53","author":"Jugheli","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0035","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.5588\/ijtld.15.0864","article-title":"Detection of katG and inhA mutations to guide isoniazid and ethionamide use for drug-resistant tuberculosis","volume":"20","author":"Bollela","year":"2016","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0036","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1128\/AAC.04058-14","article-title":"Molecular diagnosis of fluoroquinolone resistance in Mycobacterium tuberculosis","volume":"59","author":"Bernard","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0037","series-title":"Technical Report on critical concentrations for drug susceptibility testing of medicines used in the treatment of drug-resistant tuberculosis","year":"2018"},{"key":"10.1016\/j.ijantimicag.2019.04.004_bib0038","doi-asserted-by":"crossref","first-page":"5189","DOI":"10.1128\/AAC.00539-16","article-title":"Role of gyrB mutations in pre-extensively and extensively drug-resistant tuberculosis in Thai clinical isolates","volume":"60","author":"Disratthakit","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl. 2","key":"10.1016\/j.ijantimicag.2019.04.004_bib0039","first-page":"ii9","article-title":"Linezolid in vitro: mechanism and antibacterial spectrum","volume":"51","author":"Livermore","year":"2003","journal-title":"J Antimicrob Chemother"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919300901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857919300901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T17:32:47Z","timestamp":1760376767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857919300901"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":39,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0924857919300901"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.04.004","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparisons of whole-genome sequencing and phenotypic drug susceptibility testing for Mycobacterium tuberculosis causing MDR-TB and XDR-TB in Thailand","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2019.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}